recombinant

(redirected from Teriparatide)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

recombinant

Genetics
1. produced by the combining of genetic material from more than one origin
2. a chromosome, cell, organism, etc., the genetic makeup of which results from recombination
Collins Discovery Encyclopedia, 1st edition © HarperCollins Publishers 2005

recombinant

[rē′käm·bə·nənt]
(genetics)
Any new cell, individual, or molecule that is produced in the laboratory by recombinant deoxyribonucleic acid technology or that arises naturally as a result of recombination.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
In addition, the biosimilar teriparatide has been developed by Richter-Helm BioTec GmbH & Co KG and launched under the label Terrosa by Richter via its affiliates in Europe immediately following the patent expiry of the reference product in August 2019.
To the best of our knowledge, this is the first case in Turkey in whom teriparatide was administered for classical treatment-resistant hypoparathyroidism using an insulin pump and succeeded in achieving normocalcemia.
Both teriparatide and abaloparatide increased the risk of bone cancer in laboratory rats, but it is not clear if humans share the same risk.
Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis.
Sasaki et al., "Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide," Journal of Bone and Mineral Metabolism, 2014.
2014;99[5];1694-700), which also showed that the combination of teriparatide and denosumab outperformed either drug alone, and the cumulative 4-year outcomes from its extension study DATA-Switch (Lancet.
While in the past additional medications were recommended for osteoporosis, the current guidelines recommend against using raloxifene, ibandronate, teriparatide, menopausal estrogen therapy, or menopausal estrogen plus progesterone therapy for first-line pharmacologic treatment.
While convalescing, his application for teriparatide use was approved and treatment was initiated.
Therefore, we used teriparatide to progress bone union of the fracture instead of phosphate salt and active vitamin D.
W Dempster et al., "Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use," Endocrine Reviews, vol.